Scripps VIVO scripps research logo

  • Index
  • Log in
  • Home
  • People
  • Organizations
  • Research
  • Events
Search form

Bleeding complications with dual antiplatelet therapy among patients with stable vascular disease or risk factors for vascular disease: results from the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial

Academic Article
uri icon
  • Overview
  • Research
  • Identity
  • Additional Document Info
  • View All
scroll to property group menus

Overview

authors

  • Berger, P. B.
  • Bhatt, D. L.
  • Fuster, V.
  • Steg, P. G.
  • Fox, K. A. A.
  • Shao, M.
  • Brennan, D. M.
  • Hacke, W.
  • Montalescot, G.
  • Steinhubl, Steven
  • Topol, Eric

publication date

  • June 2010

journal

  • Circulation  Journal

subject areas

  • Aged
  • Aspirin
  • Disease Management
  • Double-Blind Method
  • Drug Therapy, Combination
  • Female
  • Follow-Up Studies
  • Hemorrhage
  • Humans
  • Male
  • Middle Aged
  • Myocardial Ischemia
  • Platelet Aggregation Inhibitors
  • Risk Factors
  • Survival Rate
  • Thrombosis
  • Ticlopidine
  • Vascular Diseases
scroll to property group menus

Research

keywords

  • aspirin
  • complications
  • hemorrhage
  • platelets
  • thienopyridine
scroll to property group menus

Identity

International Standard Serial Number (ISSN)

  • 0009-7322

Digital Object Identifier (DOI)

  • 10.1161/circulationaha.109.895342

PubMed ID

  • 20516378
scroll to property group menus

Additional Document Info

start page

  • 2575

end page

  • 2583

volume

  • 121

issue

  • 23

©2021 The Scripps Research Institute | Terms of Use | Powered by VIVO

  • About
  • Contact Us
  • Support